Journal
NATURE REVIEWS NEUROSCIENCE
Volume 8, Issue 8, Pages 610-622Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn2175
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA080124] Funding Source: Medline
Ask authors/readers for more resources
Despite aggressive surgery, radiotherapy and chemotherapy, malignant gliomas remain uniformly fatal. To progress, these tumours stimulate the formation of new blood vessels through processes driven primarily by vascular endothelial growth factor (VEGF). However, the resulting vessels are structurally and functionally abnormal, and contribute to a hostile microenvironment (low oxygen tension and high interstitial fluid pressure) that selects for a more malignant phenotype with increased morbidity and mortality. Emerging preclinical and clinical data indicate that anti-VEGF therapies are potentially effective in glioblastoma-the most frequent primary brain tumour- and can transiently normalize tumour vessels. This creates a window of opportunity for optimally combining chemotherapeutics and radiation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available